Amwill Health Care Limited (BOM:544353)

Market Cap	1.65B
Revenue (ttm)	439.48M
Net Income (ttm)	125.00M
Shares Out	20.00M
EPS (ttm)	8.01
PE Ratio	10.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,200
Average Volume	145,500
Open	91.00
Previous Close	90.35
Day's Range	87.10 - 91.00
52-Week Range	67.50 - 104.90
Beta	n/a
RSI	48.02
Earnings Date	May 30, 2025

About Amwill Health Care

Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions. It offers product formulations for anti-acne, dry skin, anti-aging, anti-fungal, anti-histaminic, anti-perspirant, antibiotics, skin lightening, hair care, steroid and keratolytic, sunscreen, vitiligo, peri orbital hyperpigmentation, anti-scar, topical antibiotics, antioxidants, anti-scabies, and other miscellaneous conditions. The company was incorporated in 2017 and is based in Bengaluru, India.

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544353

Financial Performance

In 2023, Amwill Health Care's revenue was 439.48 million, an increase of 45.69% compared to the previous year's 301.66 million. Earnings were 125.00 million, an increase of 301.36%.